Paresis: Clinical Trials

23 trials for Paresis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed. 23 Phase 2, 6 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 223Completed 23
Phase 16Completed 6
Phase 31Completed 1

Follow Paresis: new trials by email Literature Review of Paresis trials Research Report on Paresis

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trans Auricular Vagus Nerve Stimulation (taVNS) and Robotic Training for Paralyzed Arm After Stroke
In Motion Rehabilitation Robot - Stroke, Hemiparesis
Phase 2CompletedNorthwell Health402022-09-122026-10-06
Take Off Pounds After Stroke Trial (TOPS)
Partial meal replacement program, Dietary Counseling - Stroke, Obesity
Phase 2CompletedBeth Israel Deaconess Medical Center382019-12-012023-08-23
Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke
Transcutaneous Vagus Nerve Stimulation (tVNS), Sham Transcutaneous Vagus Nerve Stimulation (tVNS) - Stroke, Cerebrovascular Accident (CVA)
Phase 2CompletedNorthwell Health362018-08-092021-06-29
The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke
sham Doublestim, anodal Doublestim - Stroke, Cerebrovascular Accident (CVA)
Phase 1 / Phase 2CompletedNorthwell Health262016-09-012021-04-05
The Immediate Effect of Electrical Stimulation Transcranial Direct Current (tDCS) Associated With the Use of FES, in Muscle Activity of the Tibialis Anterior Muscle, Balance and Plantar Pressure Distribution of Individuals With Hemiparesis Due to Stroke
Transcranial direct current stimulation (tDCS), Functional electrical stimulation (FES), Sham stimulation - STROKE
Phase 1 / Phase 2CompletedUniversity of Nove de Julho302015-01-012016-10-25
The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project)
Neurorehabilitation therapy with cast, Neurorehabilitation therapy with splint, Neurorehabilitation bimanual - Hemiparesis, Cerebral Palsy
Phase 1 / Phase 2CompletedVirginia Polytechnic Institute and State University582015-01-012022-03-11
Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy
Xeomin, Botox® - Cerebral Palsy, Spastic Paraplegia and Hemiparesis
Phase 2CompletedMerz Pharmaceuticals GmbH642014-07-012017-01-26
Pilot Investigation of Stem Cells in Stroke Phase II Efficacy
CTX DP - Ischaemic Stroke, Cerebral Infarction
Phase 2CompletedReNeuron Limited232014-06-012018-07-23
Music Therapy for The Rehabilitation of Upper Limb With Stroke Patients
Therapeutic Instrumental Music Performance - Hemiparesis
Phase 2CompletedAnglia Ruskin University102014-01-012016-01-05
Children With Hemiparesis Arm and Hand Movement Project (CHAMP Study)
Variations in Pediatric Constraint-Induced Movement Therapy (P-CIMT) versus usual and customary rehabilitation - Hemiparesis, Cerebral Palsy
Phase 2CompletedVirginia Polytechnic Institute and State University1242013-07-012022-03-25
Robot Therapy for Rehabilitation of Hand Movement After Stroke
HEXORR - Stroke, Movement Disorders
Phase 2CompletedThe Catholic University of America152012-10-042020-09-03
Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery
tDCS: noninvasive brain stimulation, Constraint induced movement therapy (CIMT), Sham tDCS: placebo noninvasive brain stimulation - Stroke
Phase 1 / Phase 2CompletedThe Cleveland Clinic672011-07-012020-07-16
Does More Practice Improve Arm Movement After Stroke?
Intensive task-specific upper extremity rehabilitation - Stroke
Phase 2CompletedWashington University School of Medicine852010-05-012017-02-24
Improving Stroke Rehabilitation: Spacing Effect and D-cycloserine
D-cycloserine + distributed treatment, D-cycloserine + condensed treatment, Placebo + distributed treatment - Stroke
Phase 2CompletedUS Department of Veterans Affairs242009-07-012014-03-07
The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke
Botox®, saline solution - Stroke
Phase 1 / Phase 2CompletedNew York Presbyterian Hospital122009-06-012011-04-26
Functional Recovery in Stroke Patients With Task-Specific Robot-Aided Arm Therapy
robot therapy (ARMin), conventional therapy - Stroke, Upper Extremity Paresis
Phase 2 / Phase 3CompletedUniversity of Zurich762008-07-012013-04-22
Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke
Armodafinil, Placebo - Stroke, Cerebrovascular Accident
Phase 2CompletedBurke Rehabilitation Hospital192008-01-012019-11-04
Treatments for Recovery of Hand Function in Acute Stroke Survivors
Neuromuscular electrical stimulator - Stroke, Acute, Stroke
Phase 1 / Phase 2CompletedMetroHealth Medical Center212007-07-012018-12-19
Bilateral Training Versus Unilateral Training in Stroke
bilateral upper extremity training, Unilateral upper extremity training - Stroke, Hemiparesis
Phase 2CompletedUniversity of Illinois at Chicago242005-05-012014-08-04
Trial of Ropinirole in Motor Recovery After Stroke
Ropinirole (+ physical therapy), (vs.) Placebo + physical therapy - Cerebrovascular Accident, Hemiparesis
Phase 2CompletedUniversity of California, Irvine522003-10-012016-11-01

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Stroke (18)  ·  Cerebral Palsy (3)  ·  Brain Injuries (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Cerebral Infarction (1)  ·  Hemiplegia (1)  ·  Intervertebral Disc Displacement (1)  ·  Ischemic Stroke (1)  ·  Movement Disorders (1)  ·  Muscle Hypotonia (1)  ·  Muscle Spasticity (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Pain (1)

Broader conditions

Nervous System Diseases (23)  ·  Neurologic Manifestations (23)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Signs and Symptoms (23)  ·  Brain Diseases (22)  ·  Central Nervous System Diseases (22)  ·  Cardiovascular Diseases (19)  ·  Cerebrovascular Disorders (19)  ·  Vascular Diseases (19)  ·  Brain Damage, Chronic (3)  ·  Musculoskeletal Diseases (2)  ·  Neuromuscular Manifestations (2)  ·  Paralysis (2)  ·  Body Weight (1)  ·  Bone Diseases (1)

Interventions

Botulinum Toxins, Type A (2)  ·  Stroke Rehabilitation (2)  ·  Transcranial Direct Current Stimulation (2)  ·  Constraint Induced Movement Therapy (1)  ·  Cycloserine (1)  ·  Fluoridation (1)  ·  Modafinil (1)  ·  Music Therapy (1)  ·  Nutrition Assessment (1)  ·  POLR1G protein, human (1)  ·  Physical Therapy Modalities (1)  ·  Resistance Training (1)  ·  Saline Solution (1)  ·  Splints (1)  ·  Transcutaneous Electric Nerve Stimulation (1)

Sponsors

Northwell Health (3)  ·  US Department of Veterans Affairs (3)  ·  Virginia Polytechnic Institute and State University (2)  ·  Anglia Ruskin University (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Burke Rehabilitation Hospital (1)  ·  Merz Pharmaceuticals GmbH (1)  ·  MetroHealth Medical Center (1)  ·  New York Presbyterian Hospital (1)  ·  ReNeuron Limited (1)  ·  The Catholic University of America (1)  ·  The Cleveland Clinic (1)  ·  University Hospital Tuebingen (1)  ·  University of California, Irvine (1)  ·  University of Illinois at Chicago (1)

Countries

United States (16)  ·  United Kingdom (2)  ·  Brazil (1)  ·  Russia (1)  ·  Switzerland (1)

Top investigators

Armin Curt, Prof. (1)  ·  Bruce T Volpe, MD (1)  ·  Catherine E Lang, PT, PhD (1)  ·  Daniel M Corcos, PhD (1)  ·  Danielle M Kerkovitch, Ph.D. (1)  ·  David Wolff, Ph.D. Special Assistant to the Director (1)  ·  Ela B Plow, PhD PT (1)  ·  Jayme S Knutson, PhD (1)  ·  Keith W Muir (1)  ·  Mary E Stoykov, PhD (1)  ·  Michael Weller, Prof. (1)  ·  Pamela W. Duncan, PhD MA BS (1)  ·  Pasquale Fonzetti, MD, PhD (1)  ·  Peter Lum (1)

Results publications

PMID 19520987, PMID 19531608, PMID 24119615, PMID 24382580, PMID 25938519, PMID 26752061, PMID 27724916, PMID 28643570, PMID 30782701, PMID 32232101, PMID 33175411, PMID 34649982, PMID 34899170, PMID 36772802, PMID 37231793

NIH funding

2014 (1), K01HD069504 (1)